Characterization of biochemical recurrence after radical prostatectomy

Urologia Internationalis

Volumn 77, Issue 2, 2006, Pages 130-134

  Molitierno, Joseph ^a   Evans, Aubrey ^a   Mohler, James L ^a   Wallen, Eric ^a   Moore, Dominic ^a   Pruthi, Raj S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Biochemical recurrence after radical prostatectomy; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CAUCASIAN; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 33746927574     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093906     Document Type: Article

References (13)

1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2004. CA Cancer J Clin 2004;52:23-47.
2. Trapasso JG, deKernion JB, Smith RB, Dorey F: The incidence and significance of detectable levels of serum prostate-specific antigen after radical prostatectomy. J Urol 1994;152:1821-1825.
3. Zinke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994;152:1850-1857.
4. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC: Serum PSA after radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 1993;20:712-725.
5. Catalona WJ, Smith DS: Five-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994;152:1837-1842.
6. Stamey TA, Yemoto C, McNeal JE: A histological analysis of probable causes of biochemical failure after prostatectomy for clinically localized T1c-T2 cancers (abstract). J Urol 1996;155(suppl):487A.
7. Patel A, Dorey F, Franklin J, deKernion JB: Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate-specific antigen doubling times and log slope prostate-specific antigen. J Urol 1997;158:1441-1445.
8. Pound CR, Partin AW, Eisenberger MA, et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591-1597.
9. Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zinke H: PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 2001;76:576-581.
10. Sobin LH, Fleming ID: TNM Classification of Malignant Tumors, ed 5. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803.
11. Gleason DF: Histologic grading of prostate cancer: a perspective. Hum Pathol 1992;23:273.
12. Schmid HP, McNeal JE, Stamey TA: Observations on the doubling time of prostate cancer: the use of serial prostate-specific antigen in patient with untreated disease as a measure of increasing cancer volume. Cancer 1993;71:2031-2040.
13. Pruthi RS, Johnstone I, Tu IP, Stamey TA: Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer. Urology 1997;49:737-742.